# Trending Content OS — Daily Run
**Run date:** 2026-09-29 | **Niche:** Health & Wellness

---

## 1. Preflight Summary

```yaml
preflight_status:
  all_sections_present: true
  missing_sections: []
  site_niche_set: true
  target_audience_set: true
  site_url_set: false
  serpapi_connected: true
  google_trends_available: true
  google_trends_tool: "serpapi_prefetch"
  active_tools: [serpapi_news, serpapi_trends, google_news_radar]
  inactive_tools: [reddit_live, twitter_live, rss_direct_fetch]
  can_run_signal_listener: true
  notes: >
    site_url not configured — self-check skipped; competitor-list fallback (configs/competitor_list.yaml)
    used to inform SERP-gap judgment. Google Trends and Google News Radar both live via
    SerpAPI pre-fetch injection — treated as primary signal sources per config.
next_action: run_signal_listener
```

---

## 2. Google News Radar Coverage Summary (144 unique headlines / 12 queries)

| Cluster | Disposition | Reasoning |
|---|---|---|
| **FDA chlorthalidone (blood pressure) recall — Class II clarification** ([The Hill](https://thehill.com/homenews/6115677-blood-pressure-medication-recalled-nationwide-under-fdas-class-ii-risk-level/), [Houston Chronicle](https://www.houstonchronicle.com/news/houston-texas/trending/article/fda-class-ii-chlorthalidone-recall-22448678.php), [NBC5](https://www.nbcdfw.com/news/local/recall-alert-local/fda-recalls-more-than-13000-bottles-of-blood-pressure-medication-after-quality-issue/4083976/), [News4JAX](https://www.news4jax.com/news/local/2026/09/28/thousands-of-bottles-of-blood-pressure-medication-recalled-nationwide/), [Dallas News](https://www.dallasnews.com/news/public-health/article/chlorthalidone-blood-pressure-tablets-recalled-fda-22453633.php)) | **RETAINED — update, P1** | Same base recall covered 09-28, but 5+ independent outlets now converge on a *new* fact: FDA classified it Class II. #1 real-time Google Trends breakout term today with confirmed news driver. |
| **Vitruvias thyroid tablet recall (Class I)** ([USA Today](https://www.usatoday.com/story/money/consumer-protection/recalls-alerts/2026/09/24/thyroid-tablet-medicine-recall-fda/91916444007/), [NewsNation](https://www.newsnationnow.com/health/fda-thyroid-tablet-recall-class-i/), [LiveNOW](https://www.livenowfox.com/news/thyroid-medication-recall-vitruvias-therapeutics-class-i)) | **REJECTED — existing** | Already covered 09-24, no new development in radar. |
| **PATHFINDER 2 / Mayo Clinic multi-cancer blood test** ([Nature](https://www.nature.com/articles/s41591-026-04618-w), [Mayo Clinic News](https://newsnetwork.mayoclinic.org/discussion/multicancer-blood-test-detects-17-cancer-types-in-large-prospective-study/)) | **REJECTED — existing, recurring** | Covered 09-23 and 09-27. Appearing a 3rd time with no new data → flagged **recurring, check for staleness** per run-history rule. |
| **Pro-nicotine "wellness" rebrand** | **REJECTED — existing, recurring** | Covered 09-23 and 09-27 verbatim. 2nd consecutive recurrence — watchlist. |
| **Senate pilot/ATC mental health bill** ([Reuters](https://www.reuters.com/business/healthcare-pharmaceuticals/us-senate-approves-legislation-address-pilot-air-traffic-control-mental-health-2026-09-25/)) | **REJECTED — existing** | Covered 09-28. |
| **REM sleep / 83 diseases study** ([ScienceDaily](https://www.sciencedaily.com/releases/2026/09/260923035930.htm)) | **REJECTED — existing** | Covered 09-25. |
| **Clinical trial diversity — Black patients excluded** ([Word In Black](https://wordinblack.com/2026/09/black-patients-arent-avoiding-clinical-trials-they-often-arent-asked/), [St. Louis American](https://www.stlamerican.com/your-health-matters/black-patients-face-barriers-to-clinical-trials/)) | **REJECTED — existing, recurring** | Covered 09-24; new radar hits are the same structural story restated. |
| **Ultra-processed food: Stanford school-menu study + CA non-UPF label law** ([Stanford Medicine](https://med.stanford.edu/news/all-news/2026/09/ultra-processed-school-food.html), [CA.gov](https://www.gov.ca.gov/2026/09/28/governor-newsom-signs-legislation-creating-non-upf-label-other-health-bills-advancing-californias-nation-leading-healthcare-strategy/)) | **RETAINED — new, P2** | Not in recent coverage. Two independent tier-1 institutional channels (research + policy) converge same week. |
| **CDC E. coli outbreak — raw milk cheese** ([CDC.gov](https://www.cdc.gov/ecoli/outbreaks/raw-milk-cheese-09-26/index.html)) | **MONITORED — P5** | Strong primary source (CDC.gov), but posted 09-25 = 96h old, exceeding the 72h freshness ceiling for recall/outbreak signals with no case-count update in radar. Held for recheck if new data emerges. |
| **Sugar recall — 1.7M lbs, allergens** ([Fox13 Tampa](https://www.fox13news.com/news/sugar-recall-1-7-million-pounds-recalled-over-possible-allergens)) | **MONITORED — P5** | Single-source only; fails 02b's 3-source/primary-notice requirement for recalls. |
| **Will Reeve testicular cancer diagnosis** ([People.com](https://people.com), Google Trends breakout) | **RETAINED — new, P2** | #2 real-time Trending Now term with confirmed story. Reframed as men's-health awareness content, not celebrity gossip. |
| **Medicaid cuts vs. medically tailored meal deliveries** ([NPR](https://www.npr.org/2026/09/26/nx-s1-5946434/medically-tailored-meal-deliveries-medicaid-cuts)) | **MONITORED — P5** | Single-source (NPR only) → Low confidence per rubric; strong topic, needs corroboration before scoring. |
| **Local wellness fairs/expos (10+ items: Baltimore, UAMS, Fredonia, Carthage, Champaign, Legion, Inter Miami, Valley State Prison, Dartmouth, NYC clubhouse)** | **REJECTED — off-category** | Local event listings, excluded per `local hospital news` / no national audience relevance. |
| **Healthcare business/AI (HealthPartners-Essentia merger, insurer AI billing, Oracle Health, Pfizer AI trial-matching)** | **REJECTED — excluded category** | Pure pharma/health-business news, not patient-facing. |
| **NIH funding under Trump (NPR charts)**, **FDA nominee Heidi Overton** | **REJECTED — brand safety** | Political/administrative framing; fails `allow_politics: false`. |
| **Psilocybin/cocaine trial (Red Light Holland PR)** | **REJECTED — 02b fail** | Company press release, promotional, no independent primary verification — conflict of interest. |
| **Texas mental health clinic fraud conviction** | **REJECTED — off-category** | Legal/fraud story, not health information. |
| Misc. thin/single-source items (Google Health app blog, Georgia Tech wearables, Indian Health Service grant, WHO pandemic statement, sickle-cell research announcement, knee-brace recruitment, meningioma radiotherapy study, "AI flooding journals" op-ed, clinical-trial-capacity Nature piece) | **REJECTED / MONITORED — weak signal** | Single-source, early-stage, or too narrow for target audience. |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-09-29T00:00:00Z"
  run_completed_at: "2026-09-29T00:00:00Z"
  total_signals_reviewed: 144
  total_signals_retained: 3
  total_rejected: 130
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 22
    brand_safety: 4
    duplicate: 8
    weak_signal: 15
    unverified_claim: 2
    other: 3
  highest_priority_topic: "FDA chlorthalidone recall — Class II classification"
  strongest_signal_source: "Google Trends Trending Now (breakout, confirmed news driver)"
  tools_unavailable: [reddit_live, twitter_live]
  notes: >
    Recurring themes flagged per run-history rule: PATHFINDER2 multi-cancer test (3rd
    consecutive appearance) and pro-nicotine "wellness" rebrand (2nd appearance) — both
    show editorial fatigue with no new development; recommend suppressing further coverage
    unless materially new data emerges. Three topics moved to Monitor rather than Reject
    (E. coli outbreak, sugar recall, Medicaid meal-delivery) due to single-source/freshness
    gaps rather than lack of merit — added to deferred_topics.yaml with 3-day recheck.
```

---

## 4. Skill 02b — Health Claim Verification Gate Routing Summary

| Topic | Risk Type | Gate Result | Primary Source | Confidence Cap |
|---|---|---|---|---|
| Chlorthalidone recall (Class II update) | Recall | **Pass — breaking-recall exception** | 5+ secondary outlets converge; FDA.gov notice not directly retrieved | **Medium (capped)** |
| Ultra-processed food / Stanford study | Medical study | **Pass** | Stanford Medicine institutional writeup (tier-1) | None |
| Sugar recall (1.7M lbs) | Recall | **Monitor** | Single source (Fox13), no primary notice, exception requires 3+ | Held |
| Psilocybin/cocaine trial | Drug/treatment claim | **Reject** | Company PR only, no independent primary source | N/A |
| E. coli raw milk cheese | Recall | **Not scored — freshness stale-reject** (96h > 72h ceiling), gate itself would have passed (CDC.gov primary) | CDC.gov | N/A |
| Will Reeve / testicular cancer | Not applicable | **Not triggered** — personal diagnosis disclosure, not a treatment/dosage/supplement claim | — | — |

---

## 5. Final Priority Board

| Priority | Topic | Publish Timing | Trend | Opportunity | Discover | Urgency | Confidence |
|---|---|---|---|---|---|---|---|
| **P1** | FDA chlorthalidone recall — Class II classification | immediate | 80 | 75 | 5 | today | Medium (capped) |
| **P2** | Ultra-processed food: Stanford study + CA non-UPF law | short_term | 61 | 84 | 5 | today | High |
| **P2** | Will Reeve testicular cancer diagnosis → awareness angle | short_term | 60 | 64 | 4 | now | Medium |
| **P5** | CDC E. coli raw milk cheese outbreak | monitor | — | — | — | — | — |
| **P5** | Sugar recall (1.7M lbs, allergens) | monitor | — | — | — | — | — |
| **P5** | Medicaid cuts vs. medically tailored meals | monitor | — | — | — | — | — |

```yaml
summary:
  total_topics: 6
  high_priority_count: 3
  immediate_actions: "Publish chlorthalidone Class II update today; queue UPF and Will Reeve pieces within 1-3 days."
```

---

## 6. Editorial Briefs

### 🔴 P1 — FDA Chlorthalidone Recall: Class II Risk Classification

```yaml
priority_level: P1
publish_timing: immediate
topic: "FDA classifies nationwide chlorthalidone blood pressure medication recall as Class II risk"
primary_entity: "Chlorthalidone (blood pressure medication)"
signal_type: recall
allowed_category: "FDA and CDC regulatory updates"
trend_strength_score: 80
opportunity_score: 75
discover_score: 5
urgency: today
confidence: medium
content_status: update
source_count: 5
recommended_angle: "Explain what 'Class II risk' actually means for the ~13,000+ affected bottles — patients shouldn't panic-stop a BP med, but should check lot numbers now."
why_now: "#1 real-time Google Trends breakout term today with a confirmed news driver; 5+ independent outlets converged in the last 24-48h on the new Class II classification, a materially new detail beyond the original 09-28 dissolution-testing story."
primary_headline: "FDA Says Recalled Blood Pressure Drug Poses 'Class II' Risk — Here's What That Means for Patients"
next_steps: "Assign to regulatory/chronic-disease writer; verify FDA.gov recall notice directly before publishing (breaking-recall exception used, confidence capped Medium until confirmed)."
notes: "Do not tell patients to stop medication abruptly — pull standard 'talk to your doctor before discontinuing BP medication' guidance into copy."
```
**Alternate headlines:** "What 'Class II Recall' Means — and Why You Shouldn't Just Stop Your Blood Pressure Pills" · "Blood Pressure Drug Recall Widens: FDA Clarifies the Real Risk Level"
**Outline:** Intro (what happened) → What Class II actually means vs. Class I → Who's affected (lot numbers, dosage) → What patients should do (don't self-discontinue) → FAQ.
**Sources:** [The Hill](https://thehill.com/homenews/6115677-blood-pressure-medication-recalled-nationwide-under-fdas-class-ii-risk-level/) (tier 2, used for Class II detail) · [Houston Chronicle](https://www.houstonchronicle.com/news/houston-texas/trending/article/fda-class-ii-chlorthalidone-recall-22448678.php) (tier 2, corroboration) · [Health.com](https://www.health.com/blood-pressure-medication-recall-september-2026-12138343) (tier 2, bottle count) · FDA.gov recall notice — **[URL unverified, confirm before publish]**.
**Expert source:** Cardiologist or clinical pharmacist — via existing published quote in Health.com/USA Today coverage, or ACC/AHA official statement on recall protocol.
**⚠️ Integrity note:** Primary FDA.gov notice not directly retrieved in this run — verify before publication (confidence capped Medium per 02b breaking-recall exception).
**SEO:** primary keyword "chlorthalidone recall class II" · supporting: "blood pressure medication recall 2026," "chlorthalidone recall lot numbers" · format: news explainer · est. word count: 700-900.

---

### 🟠 P2 — Ultra-Processed Food: Stanford Study Meets California's New Law

```yaml
priority_level: P2
publish_timing: short_term
topic: "California's new non-UPF food label collides with Stanford Medicine findings that cutting ultra-processed food from school menus is harder than expected"
primary_entity: "Ultra-processed food (UPF)"
signal_type: study_or_research
allowed_category: "nutrition and diet science"
trend_strength_score: 61
opportunity_score: 84
discover_score: 5
urgency: today
confidence: high
content_status: new
source_count: 2
recommended_angle: "Skepticism angle: the policy (non-UPF labeling) just got signed into law days after research shows the practical rollout is genuinely difficult — pair the 'why' with the 'how hard.'"
why_now: "Two independent tier-1 institutional sources converged in the same week: Stanford Medicine's feasibility study and Governor Newsom's non-UPF labeling law — a genuinely new combined story, not previously covered."
primary_headline: "California Just Passed a Law Labeling 'Ultra-Processed' Foods. A New Stanford Study Shows Why Schools Will Struggle to Comply."
next_steps: "Assign to nutrition writer; request RDN quote via Academy of Nutrition and Dietetics on UPF definitional ambiguity."
notes: "Strong evergreen/Discover potential — durable beyond the news cycle."
```
**Alternate headlines:** "What Does 'Ultra-Processed' Even Mean? California's New Law Is About to Find Out" · "The Science Behind California's Ultra-Processed Food Crackdown — and Its Biggest Obstacle"
**Outline:** Intro (the law + the study, same week) → What "ultra-processed" means (and why definitions vary) → Stanford's specific findings on school-menu feasibility → What this means for parents/schools nationally → FAQ.
**Sources:** [Stanford Medicine](https://med.stanford.edu/news/all-news/2026/09/ultra-processed-school-food.html) (tier 1, primary study data) · [CA.gov](https://www.gov.ca.gov/2026/09/28/governor-newsom-signs-legislation-creating-non-upf-label-other-health-bills-advancing-californias-nation-leading-healthcare-strategy/) (tier 1, policy text).
**Expert source:** Registered Dietitian Nutritionist or Tufts Friedman School nutrition scientist — cite via existing published commentary or the Academy of Nutrition and Dietetics' UPF position statement.
**⚠️ Integrity note:** "Ultra-processed food" has no single, universally agreed scientific definition (NOVA classification is widely used but contested) — flag this ambiguity explicitly rather than treating UPF as a settled clinical category.
**SEO:** primary keyword "ultra-processed food california law" · supporting: "non-UPF label meaning," "is ultra-processed food banned in schools," "NOVA food classification" · format: news + explainer hybrid · est. word count: 900-1100.

---

### 🟠 P2 — Will Reeve's Testicular Cancer Diagnosis: The Awareness Angle

```yaml
priority_level: P2
publish_timing: short_term
topic: "Will Reeve reveals testicular cancer diagnosis — reframed around symptoms, screening, and survival rates"
primary_entity: "Testicular cancer"
signal_type: cultural_moment
allowed_category: "chronic disease management"
trend_strength_score: 60
opportunity_score: 64
discover_score: 4
urgency: now
confidence: medium
content_status: new
source_count: 1
recommended_angle: "Use the trending name as the hook, but the actual content is evidence-based men's health education — symptoms, self-exam, screening, and prognosis data — not celebrity speculation."
why_now: "Real-time Google Trends breakout (#2 term today) with a confirmed news driver; search interest is happening now, and the informational gap (symptoms/screening) is exactly what people are searching for alongside the name."
primary_headline: "Will Reeve Has Testicular Cancer — Here's What the Symptoms, Screening, and Survival Rates Actually Look Like"
next_steps: "Assign quickly — trending-now stories decay fast; publish within 24-48h to capture search interest window."
notes: "Borderline category call — passed on audience_relevance (78) + clear evidence angle + reframed away from pure celebrity-wellness territory; editorial judgment applied per borderline criteria."
```
**Alternate headlines:** "What Is Testicular Cancer? Symptoms, Risk Factors, and Screening Explained" · "Will Reeve's Diagnosis Is a Reminder: Testicular Cancer Is Highly Treatable — If Caught Early"
**Outline:** Intro (news hook, brief + respectful) → What testicular cancer is, who's at risk → Symptoms and self-exam guidance → Screening/treatment/survival data → FAQ.
**Sources:** People.com (tier 2, news hook) · American Cancer Society testicular cancer statistics — **[URL to be confirmed at drafting]** · CDC/NIH cancer screening guidance — **[URL to be confirmed at drafting]**.
**Expert source:** Board-certified urologist or oncologist — cite via ACS published guidance or existing physician commentary on testicular cancer screening.
**⚠️ Integrity note:** Do not speculate on the individual's specific prognosis, stage, or treatment plan beyond what he has publicly disclosed — keep all clinical detail general and evidence-based (ACS/NCI data), not tied to his personal case.
**SEO:** primary keyword "testicular cancer symptoms" · supporting: "testicular cancer screening," "testicular cancer survival rate," "will reeve health" · format: news-hook explainer · est. word count: 600-800.

---

## 7. Rejected Topics Log (selected — full list in Section 2 table)

| Topic | Reason |
|---|---|
| PATHFINDER2 multi-cancer blood test | Existing — 3rd consecutive recurrence, no new data |
| Pro-nicotine wellness rebrand | Existing — 2nd recurrence |
| Vitruvias thyroid recall (Class I) | Existing, covered 09-24 |
| Senate pilot/ATC mental health bill | Existing, covered 09-28 |
| REM sleep / 83 diseases study | Existing, covered 09-25 |
| Clinical trial diversity (Black patients) | Existing, covered 09-24 |
| Psilocybin/cocaine trial | 02b reject — unverifiable, company PR conflict of interest |
| Local wellness fairs/expos (10 items) | Off-category — local event listings |
| Healthcare business/AI (merger, billing, Oracle, Pfizer) | Excluded category — pure pharma/business |
| NIH funding under Trump / FDA nominee | Brand safety — political framing |
| Texas mental health clinic fraud | Off-category — legal/fraud, not health info |
| Misc. single-source/early-stage items (9) | Weak signal |

---

## 8. Integrity Flags Callout

⚠️ **Chlorthalidone recall:** FDA.gov primary notice not directly retrieved this run — confidence capped Medium via breaking-recall exception; verify before publishing.
⚠️ **Ultra-processed food:** "Ultra-processed" lacks a single agreed scientific definition — must be stated explicitly, not treated as settled.
⚠️ **Will Reeve:** Keep clinical content general/evidence-based (ACS/NCI); do not speculate on his personal prognosis or treatment.

---

## 9. Run Notes

- Google Trends and Google News Radar both available via SerpAPI pre-fetch; no estimation fallback needed.
- `site_url` not configured — competitor-list fallback used for SERP-gap/duplicate context on all retained candidates.
- Three topics held at Monitor (P5) rather than scored due to single-source sourcing or freshness-ceiling breach, not lack of merit — added to `data/deferred_topics.yaml` with a 3-day recheck.
- Recurring-theme watchlist updated: PATHFINDER2 (3rd appearance, suppress further coverage absent new data), pro-nicotine wellness (2nd appearance, watch).
- `data/run_history.yaml` archived with today's entry (9 total signals reviewed from radar sample, 3 retained, 6 monitored/rejected-with-reason, 130 rejected outright).